Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Clin Oncol. Oct 10, 2014; 5(4): 621-632
Published online Oct 10, 2014. doi: 10.5306/wjco.v5.i4.621
Figure 2
Figure 2 C4. 4A in pulmonary squamous cell carcinoma. Panels A-E: C4.4A expression as detected by immunohistochemistry with a polyclonal antibody in normal bronchial epithelium (A), hyperplasia (B), metaplasia (C), dysplasia (D) and invasive squamous cell carcinoma (SCC) (E). A, B, D and C, E are reproduced with permission from Jacobsen et al[34], 2012 and BestPractice Onkologi, Denmark[89], respectively. Panel F: Kaplan-Meier curves for the survival of SCC patients, which is independent of C4.4A scores, here stratified by tertiles (red: Lowest level of C4.4A; blue: Intermediate level of C4.4A; green: Highest level of C4.4A). Modified from Jacobsen et al[33], 2013.